What is SEFAM PL 10/5?
SEFAM PL 10/5 contains Perindopril Arginine(an ACE inhibitor) and Amlodipine(a calcium channel blocker).
It is a substitution therapy for the treatment of high blood pressure and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine.
Treatment should not be initiated with this combination.
Detailed information related to SEFAM PL 10/5 Tablets’s uses, side-effects, reviews, questions, interactions, and precautions is as follows:
SEFAM PL 10/5 Uses
SEFAM PL 10/5 Tablets is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
SEFAM PL 10/5 Working, Mechanism of Action and Pharmacology
SEFAM PL 10/5 improves the patient’s condition by performing the following functions:
Perindopril Arginine-angiotensin converting enzyme(ACE) inhibitor:
Amlodipine-calcium channel blocker (CCB):
SEFAM PL 10/5 Composition and active ingredients:
Each film coated SEFAM PL 10/5 Tablets is having various prescription medications as given below:
SEFAM PL 10/5 – Side-effects
The following is a list of possible side-effects that may occur in medicines that contain SEFAM PL 10/5. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.
SEFAM PL 10/5 – Precautions & How to Use
Use as directed by your doctor or follow the instructions printed on the product insert.
Consult a doctor, if the condition persists or worsens.
Important counseling points are listed below:
Keep out of reach of the children.
The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:
ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.
AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.
NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .
EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.
OCEANIA: Australia, New Zealand, Fiji, and so forth.